Teva-Tochter TAPI ernennt Serge Rogasik zum CEO

• TAPI, eine Einheit von Teva Pharmaceutical Industries Ltd., hat Serge Rogasik zum CEO ernannt.
• Rogasik war zuletzt Präsident und CEO von Kensing, einem von One Rock Capital Partners kontrollierten Spezialzutatenhersteller.
• Zuvor leitete er Transformations- und Wachstumsinitiativen bei Vantage Specialty Chemicals sowie Addivant; frühere Stationen: BASF, GE, Eastman, Rhône-Poulenc, Colgate-Palmolive.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva Pharmaceutical Industries Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609301632OMX_____CNEWS_EN_GNW1001275608_en) on September 30, 2026, and is solely responsible for the information contained therein.